VCP
ASXC

Verus Capital Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Verus Capital Partners’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50
Closed – – 1617
2019
Q4 		$0 Buy
+50
New +$174 ﹤0.01% 1555

Other funds holding ASXC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Verus Capital Partners's ASXC Position: Q1 2020 in Review

Verus Capital Partners sold out of Asensus Surgical, Inc. (ASXC) in Q1 2020, closing a stake of 50 shares.

Verus Capital Partners first reported a position in ASXC in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 82 funds tracked by Wall St. Rank hold ASXC as of Q1 2020.

  • Verus Capital Partners reported no remaining Asensus Surgical, Inc. position as of Q1 2020 after selling out during the quarter.
  • Verus Capital Partners sold 50 Asensus Surgical, Inc. shares in Q1 2020.
  • Verus Capital Partners first reported a position in Asensus Surgical, Inc. in Q4 2019 and held it in 1 quarter.
  • Verus Capital Partners's Asensus Surgical, Inc. position peaked at $0 in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.